Prof. Serkan KUYUMCU

Publication Network

Articles 85

1. Threshold optimization for lesion size in lutetium-177 single-photon emission computed tomography imaging: a phantom-based evaluation

Mutlu E., Şenişik A. M., Kovan B., Kuyumcu S., Demir B.

NUCLEAR MEDICINE COMMUNICATIONS , vol.20, no.NOVEMBER, pp.1079-1082, 2025 (Scopus)

2. 68Ga-Trivehexin PET/CT uptake in malignant and fibrotic lung tissue: refining diagnostic applications

Kuyumcu S., Denizmen Zorba D., Özkan Z. G.

European Journal of Nuclear Medicine and Molecular Imaging , vol.52, no.10, pp.3513-3514, 2025 (SCI-Expanded, Scopus)

3. Detection of Recurrent Parathyroid Cancer Using 68Ga-Trivehexin PET/CT

Denizmen Zorba D., Kuyumcu S., Kubat Uzum A., Isik E. G., Sanli Y.

Clinical Nuclear Medicine , vol.50, no.7, 2025 (SCI-Expanded, Scopus)

4. Impact of extended [(177)Lu] Lu-PSMA-617 therapy on absorbed kidney dose and CKD-EPI values: how long can therapy be safely continued?

Topal E., Kovan B., İribas A., Kuyumcu S., Basaran M., Malçok Demirtaş A., et al.

European journal of nuclear medicine and molecular imaging , 2025 (SCI-Expanded, Scopus)

5. [⁶⁸Ga]Ga-FAPI04 Outperforms [¹⁸F]FDG PET/CT for Detecting Nodal Metastasis of Head and Neck Squamous Cell Carcinoma: A Single-Center Experience

Kuyumcu S., Isik E. G., ŞEN C., Has-Şimsek D., Başaran B., Özkan Z. G., et al.

CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS , vol.40, no.2, pp.122-129, 2025 (SCI-Expanded, Scopus) Sustainable Development

6. Reflections on Terbium-149: advancing preclinical research in targeted alpha therapy.

Kuyumcu S., Şanlı Y.

European journal of nuclear medicine and molecular imaging , 2025 (SCI-Expanded)

7. The Utility of (18)F-FDG PET/CT in Detecting Multiple Metastases in Papillary Renal Cell Carcinoma.

Oflas M., Has Şimşek D., Kuyumcu S., Yılmaz Kıran M., Şanlı Y.

Molecular imaging and radionuclide therapy , vol.34, no.1, pp.64-65, 2025 (ESCI)

8. Head-to-Head Comparison of ⁶⁸Ga-FAPI-04 and ⁶⁸Ga-DOTA-TATE PET/CT in Recurrent Medullary Thyroid Cancer

Isik E. G., Has Simsek D., GÜL N., ERTÜRK Ş. M., Buyukkaya F., Soyluk Selcukbiricik O., et al.

CLINICAL NUCLEAR MEDICINE , vol.50, no.2, 2025 (SCI-Expanded, Scopus) Sustainable Development

9. Evaluating the efficacy of [¹⁷⁷Lu]Lu-FAP-2286 in combination therapy for metastatic breast cancer

Kuyumcu S., Has-Şimşek D.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , vol.51, no.13, pp.4188-4189, 2024 (SCI-Expanded, Scopus)

10. ⁶⁸Ga-Trivehexin PET/CT: a promising novel tracer for primary hyperparathyroidism

Kuyumcu S., Denizmen D., Has-Simsek D., Poyanli A., Uzum A. K., Buyukkaya F., et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , vol.51, no.13, pp.3912-3923, 2024 (SCI-Expanded, Scopus)

11. EVALUATING LONG-TERM EXTERNAL DOSES AT SHORT RANGE IN PATIENTS RECEIVING 131I TREATMENT FOR DIFFERENTIATED THYROID CARCINOMA

KOVAN B., ARSLAN D. F., Civan C., IŞIK E. G., DEMİR B., KUYUMCU S., et al.

JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI , 2024 (ESCI)

12. Combination of ⁶⁸Ga-FAPI-04 and Dedicated Breast PET (MAMMI PET) Outperformed Breast MRI and ¹⁸F-FDG PET/CT by Revealing Nipple and Skin Involvement of Breast Cancer

Has Simsek D., Oflas M., Yilmaz R., Tukenmez M., Kuyumcu S.

CLINICAL NUCLEAR MEDICINE , vol.49, no.6, 2024 (SCI-Expanded, Scopus) Sustainable Development

13. The Role of [¹⁸F]FDG PET/CT in the Characterization of Thymic Epithelial Tumors at Initial Stage

Civan C., Ozkan Z. G., Ozkan B., Isik E. G., Erdogdu E., Simsek D. H., et al.

CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS , vol.39, no.5, pp.373-380, 2024 (SCI-Expanded, Scopus)

14. Diagnosis and Evaluation of Treatment Response in Relapsing Polychondritis Using18F-FDG PET/CT Tekrarlayan Polikondrit Tanısında ve Tedavi Yanıt Değerlendirmesinde18F-FDG PET/BT

Civan C., Işık E. G., Şimşek D. H., Altınkaynak M., Kuyumcu S.

Molecular Imaging and Radionuclide Therapy , vol.33, no.2, pp.109-111, 2024 (ESCI, Scopus, TRDizin)

15. Influencing factors of lung shunt fraction in transarterial radioembolization treatment

Kovan B., CİVAN C., Isik E. G., Simsek D., Ozkan Z. G., Buyukkaya F., et al.

CLINICAL AND TRANSLATIONAL IMAGING , vol.12, no.2, pp.205-211, 2024 (SCI-Expanded, Scopus) Sustainable Development

16. 18F-FDG and 68Ga-FAPI-04 PET/CT Findings of a Rare Epithelialmyoepithelial Carcinoma Arising From Ex Pleomorphic Adenoma of Parotid

CİVAN C., HAS ŞİMŞEK D., VURALLI BAKKALOĞLU D., KUYUMCU S.

Molecular Imaging and Radionuclide Therapy , vol.0, 2024 (ESCI)

17. The inferior performance of [⁶⁸Ga]Ga-FAPI-04 PET/CT as a diagnostic and theranostic biomarker in [¹⁷⁷Lu]Lu-DOTATATE refractory well-differentiated neuroendocrine tumors

Has Simsek D., Guzel Y., Denizmen D., Sanli Y., Buyukkaya F., Kovan B., et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , vol.51, no.3, pp.828-840, 2024 (SCI-Expanded, Scopus) Sustainable Development

18. The role of [⁶⁸ Ga]Ga-FAPI-04 PET/CT in renal cell carcinoma: a preliminary study

CİVAN C., Kuyumcu S., Has Simsek D., Sanli O., Isik E. G., Ozkan Z. G., et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , vol.51, no.3, pp.852-861, 2024 (SCI-Expanded, Scopus)

19. Influence of Early Versus Delayed Hepatic Artery Perfusion Scan on ⁹⁰Y Selective Internal Radiation Therapy Planning

KOVAN B., DENİZMEN D., Civan C., KUYUMCU S., IŞIK E. G., HAS ŞİMŞEK D., et al.

CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS , 2024 (SCI-Expanded)

20. Isolated Adrenal Metastases of Castration-Resistant Prostate Cancer

Topal E., Has Simsek D., Vatansever S., Sanli Y., Kuyumcu S.

CLINICAL NUCLEAR MEDICINE , vol.49, no.1, 2024 (SCI-Expanded, Scopus) Sustainable Development

21. FAPI-Negative FDG-Avid Metastatic Relapse of Breast Cancer on PET/CT.

Civan C., Has Simsek D., Isik E. G., Sanli Y., Kuyumcu S.

Clinical nuclear medicine , vol.48, no.8, 2023 (SCI-Expanded, Scopus) Sustainable Development

22. Utility of 68 Ga-FAPI-04 PET/CT in Adenoid Cystic Carcinoma Compared With 18 F-FDG PET/CT : Two Case Reports.

Civan C., Isik E. G., Has Simsek D., Buyukkaya F., Kuyumcu S.

Clinical nuclear medicine , vol.48, no.7, 2023 (SCI-Expanded, Scopus) Sustainable Development

23. An anthropomorphic body phantom for the determination of calibration factor in radionuclide treatment dosimetry.

Kovan B., Demir B., Işık E. G., Has Şimşek D., Özkan Z. G., Kuyumcu S., et al.

Radiation protection dosimetry , 2023 (SCI-Expanded, Scopus)

24. 68 Ga-FAPI04 Versus 68 Ga-DOTATATE PET/CT in a Patient With Multiple Meningioma.

Denizmen D., Isik E. G., Buyukkaya F., Kuyumcu S.

Clinical nuclear medicine , vol.48, no.5, 2023 (SCI-Expanded, Scopus)

25. 68 Ga-FAPI-04 PET/CT and 18 F-FDG PET/CT in Metastatic Papillary Renal Cell Cancer.

Civan C., Isik E. G., Karadogan S., Sanli Y., Kuyumcu S.

Clinical nuclear medicine , vol.48, no.5, 2023 (SCI-Expanded, Scopus) Sustainable Development

26. 18F-FDG and 68Ga-FAPI-04 PET/CT in Evaluating Clear-Cell Endometrial Cancer.

Kiran M. Y., Has Simsek D., Sanli Y., Kuyumcu S.

Clinical nuclear medicine , vol.48, no.2, 2023 (SCI-Expanded, Scopus) Sustainable Development

27. SPECT/CT Lymphoscintigraphy Guidance Simplifies and Improves Targeted Axillary Dissection of the Clipped Nodes After Neoadjuvant Chemotherapy in Initially Node-Positive Breast Cancer

Has Simsek D., Emiroglu S., Yilmaz R. S., Bayram A., Isik E. G., Tukenmez M., et al.

CLINICAL NUCLEAR MEDICINE , vol.47, no.11, 2022 (SCI-Expanded, Scopus) Sustainable Development

28. PET Imaging of Endometrial Cancer

CİVAN C., KUYUMCU S.

NUCLEAR MEDICINE SEMINARS , vol.8, 2022 (Peer-Reviewed Journal)

29. Head to Head Comparison of [Ga-68]Ga-FAPI-04 and [Ga-68]Ga-DOTATATE PET/CT in Patients With Recurrence Medullary Thyroid Carcinoma

Isik E., Civan C., Simsek D. H., Ozkan Z. G., Gul N., Ertürk Bozkurtoğlu Ş. N., et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , vol.49, no.SUPPL 1, 2022 (SCI-Expanded)

30. [68Ga]Ga-FAPI-04 and [18F]FDG PET/CT in Patients With Primary Liver Malignancies

Karadogan S., Sanli Y., Ertürk Bozkurtoğlu Ş. N., Ibis A. C., Kuyumcu S.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , vol.49, no.SUPPL 1, 2022 (SCI-Expanded)

31. Incidental Cardiac Ga-68-FAPI-04 Uptake Related to Cardiovascular Diseases: Case Reports

Denizmen D., Simsek D. H., Isik E. G., Mudun A., Kuyumcu S.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , vol.49, no.SUPPL 1, 2022 (SCI-Expanded) Sustainable Development

32. Outcome of 177 Lu-PSMA Radionuclide Treatment in Advanced Prostate Cancer and Its Association With Clinical Parameters : A Single-Center Experience.

Has Simsek D., Kuyumcu S., Karadogan S., Ozkan Z. G., Isik E. G., Basaran M., et al.

Clinical nuclear medicine , vol.47, no.8, 2022 (SCI-Expanded, Scopus) Sustainable Development

33. Bilateral Testicular Mass Presenting as a Rare Manifestation of Extramedullary Plasmacytoma on 18F-FDG PET/CT.

Civan C., Apaydin Arikan E., Has Simsek D., Sanli O., Kuyumcu S.

Clinical nuclear medicine , vol.47, no.3, 2022 (SCI-Expanded, Scopus)

34. Comparison of 2D planar and 3D volumetric methods for estimation of split renal function by 99(m)Tc-DMSA scintigraphy

Civan C., Has Simsek D., Kiran M. Y., Isik E. G., Ozkan Z. G., Sanli Y., et al.

PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS , vol.95, pp.83-88, 2022 (SCI-Expanded, Scopus)

35. Ga-68-PSMA Uptake Patterns of Clear Cell Renal Carcinoma Across Different Histopathological Subtypes

Oflas M., Ozluk Y., Sanli O., Ozkan Z. G., Kuyumcu S.

CLINICAL NUCLEAR MEDICINE , vol.47, no.1, 2022 (SCI-Expanded, Scopus)

36. Prognostic value of FDG PET-CT in suspected recurrence of colorectal carcinoma: survival outcomes of a 10-year follow-up : FDG PET in recurrent colorectal CA.

ozkan Z. G., Has Simsek D., Kuyumcu S., Oflas M., Isik E. G., Dogan I., et al.

Annals of nuclear medicine , vol.36, no.1, pp.52-60, 2022 (SCI-Expanded, Scopus) Sustainable Development

37. Fibroblast Activation Protein-Targeted PET Imaging of Metastatic Castration-Resistant Prostate Cancer Compared With 68Ga-PSMA and 18F-FDG PET/CT.

Isik E. G., Has-Simsek D., Sanli O., Sanli Y., Kuyumcu S.

Clinical nuclear medicine , vol.47, no.1, 2022 (SCI-Expanded, Scopus) Sustainable Development

38. [Ga-68]-Pentixafor PET/CT imaging of lymphoproliferative malignancies

Kuyumcu S., Kiran M. Y., APAYDIN ARIKAN E., YEGEN G., Sanli Y.

CLINICAL AND TRANSLATIONAL IMAGING , vol.9, no.6, pp.641-648, 2021 (SCI-Expanded, Scopus)

39. Liver metastases from medullary thyroid carcinoma detected on ⁶⁸Ga-FAPI-04 PET/CT.

Kuyumcu S., Isik E. G., Sanli Y.

Endocrine , vol.74, pp.727-728, 2021 (SCI-Expanded, Scopus)

40. 225Ac-Prostate-Specific Membrane Antigen Therapy for Castration-Resistant Prostate Cancer: A Single-Center Experience.

Sanli Y., Kuyumcu S., Simsek D., Büyükkaya F., Civan C., Isik E. G., et al.

Clinical nuclear medicine , vol.46, no.12, pp.943-951, 2021 (SCI-Expanded, Scopus) Sustainable Development

41. CXCR4 Expression Demonstrated by 68Ga-Pentixafor PET/CT Imaging in a Case of Systemic Mastocytosis Mimicking Lymphoma.

Kiran M. Y., Apaydin Arikan E., Sanli Y., Yegen G., Kuyumcu S.

Clinical nuclear medicine , vol.46, 2021 (SCI-Expanded, Scopus)

42. Fibroblast-Activated Protein Inhibitor PET/CT: Cancer Diagnosis and Management.

Kuyumcu S., Sanli Y., Subramaniam R. M.

Frontiers in oncology , vol.11, pp.758958, 2021 (SCI-Expanded, Scopus)

43. Demonstration of in vivo estrogen receptor status with 16 alpha- [F-18]fluoro-17 beta-oestradiol (FES) PET/CT in a rare case of benign metastasizing leiomyoma

Has Simsek D., Kuyumcu S., Ozkan Z. G., Vuralli Bakkaloglu D., Bayram A., Topuz S., et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , vol.48, no.12, pp.4101-4102, 2021 (SCI-Expanded, Scopus)

44. Prognostic significance of ⁶⁸Ga-Pentixafor PET/CT in multiple myeloma recurrence: a comparison to ¹⁸F-FDG PET/CT and laboratory results.

Kuyumcu S., Isik E. G., Tiryaki T. O., Has-Simsek D., Sanli Y., Buyukkaya F., et al.

Annals of nuclear medicine , vol.35, no.10, pp.1147-1156, 2021 (SCI-Expanded, Scopus)

45. Role of 18F FDG PET/CT In Pediatric Malign Melanoma

IŞIK E. G., Kuyumcu S., Simsek D. H., Bay S. B., Kebudi R., Unal S. N.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , vol.48, no.SUPPL 1, 2021 (SCI-Expanded)

46. Safety of Fibroblast Activation Protein-Targeted Radionuclide Therapy by a Low-Dose Dosimetric Approach Using Lu-177-FAPI04

Kuyumcu S., Kovan B., Sanli Y., Buyukkaya F., Has Simsek D., Özkan Z. G., et al.

CLINICAL NUCLEAR MEDICINE , vol.46, no.8, pp.641-646, 2021 (SCI-Expanded, Scopus) Sustainable Development

47. Can PSMA-based tumor burden predict response to docetaxel treatment in metastatic castration-resistant prostate cancer?

Has Simsek D., Kuyumcu S., Karadogan S., Oflas M., Isik E. G., Ozkan Z. G., et al.

ANNALS OF NUCLEAR MEDICINE , vol.35, no.6, pp.680-690, 2021 (SCI-Expanded, Scopus) Sustainable Development

48. 177Lu-PSMA Therapy for Metastatic Testicular Mixed Germ Cell Tumor.

Has Simsek D., Civan C., Ekenel M., Kuyumcu S., Sanli Y.

Clinical nuclear medicine , vol.46, no.5, pp.415-418, 2021 (SCI-Expanded, Scopus)

49. Somatostatin receptor-positive breast lesions on Ga-68-DOTATATE PET/CT

Simsek D., Isik E. G., Engin M. N., Kuyumcu S., Mudun A., Sanli Y.

ANNALS OF NUCLEAR MEDICINE , vol.35, no.2, pp.270-277, 2021 (SCI-Expanded, Scopus)

50. THE IMPACT OF 68GA-PSMA PET/CT ON THERAPY MANAGEMENT OF HIGH RISK PROSTATE CANCER

Simsek D., Isik E. G., Civan C., Ozkan Z. G., Kuyumcu S., Iribas A., et al.

JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI , vol.84, no.1, pp.48-56, 2021 (ESCI, TRDizin) Sustainable Development

51. Does bone scintigraphy still have a role in the era of 68 Ga-PSMA PET/CT in prostate cancer?

Simsek D., ŞANLI Y., CİVAN C., Engin M. N., IŞIK E. G., ÖZKAN Z. G., et al.

ANNALS OF NUCLEAR MEDICINE , vol.34, no.7, pp.476-485, 2020 (SCI-Expanded, Scopus) Sustainable Development

52. THE ROLE OF 18F-FDG PET-CT IN DIAGNOSIS AND PREDICTION OF PROGNOSIS IN MALIGNANT PLEURAL MESOTHELIOMA

Simsek D., Kuyumcu S., Sanli Y., Ozkan Z. G., Ozkan B., Turkmen C., et al.

JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI , vol.82, no.4, pp.168-173, 2019 (ESCI)

53. Evidence of Prostate-Specific Membrane Antigen Expression in Hepatocellular Carcinoma Using 68Ga-PSMA PET/CT

Kuyumcu S., Has-Simsek D., Iliaz R., Sanli Y., Buyukkaya F., Akyuz F., et al.

CLINICAL NUCLEAR MEDICINE , vol.44, no.9, pp.702-706, 2019 (SCI-Expanded, Scopus)

54. Clinical Impact of Lower-Limb Imaging in Ga-68-PSMA PET/CT for Patients with Prostate Cancer

Simsek D., Sanli Y., Kuyumcu S., Engin M. N., Buyukkaya F., Demirci E.

JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY , vol.47, no.3, pp.233-237, 2019 (ESCI, Scopus) Sustainable Development

55. Radionuclide Therapy With 177Lu-PSMA in a Case of Metastatic Adenoid Cystic Carcinoma of the Parotid.

Has S., Kuyumcu S., Agaoglu F., Unal S. N.

Clinical nuclear medicine , vol.44, pp.764-766, 2019 (SCI-Expanded, Scopus)

56. Imaging of Chemokine Receptor CXCR4 in Mycosis Fungoides Using 68Ga-Pentixafor PET/CT

Kuyumcu S., Yilmaz E., Buyukkaya F., Ozkan Z. G., Unal S. N.

CLINICAL NUCLEAR MEDICINE , vol.43, no.8, pp.606-608, 2018 (SCI-Expanded, Scopus)

57. Neuroendocrine Tumor Diagnosis and Management: <sup>68</sup>Ga-DOTATATE PET/CT.

Sanli Y., GARG I., KANDATHIL A., KENDI T., ZANETTI M., Kuyumcu S., et al.

AJR. American journal of roentgenology , vol.211, pp.267-277, 2018 (SCI-Expanded, Scopus)

58. ⁶⁸Ga-DOTATATE PET-CT imaging in carotid body paragangliomas.

Simsek D., Sanli Y., Kuyumcu S., Basaran B., Mudun A.

Annals of nuclear medicine , vol.32, no.4, pp.297-301, 2018 (SCI-Expanded, Scopus)

59. POST-THERAPY IMAGING AFTER RADIOACTIVE IODINE THERAPY FOR DIFFERENTIATED THYROID CANCER: THE CONTRIBUTION OF SPECT-CT IMAGING TO PLANAR IMAGING

Has Simsek D., Sanli Y., Kuyumcu S., Yilmaz E., Ozkan Z. G., Turkmen C., et al.

JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI , vol.81, no.4, pp.106-114, 2018 (ESCI) Sustainable Development

60. Prediction of outcome in pediatric Hodgkin lymphoma based on interpretation of (18)FDG-PET/CT according to Delta SUVmax, Deauville 5-point scale and IHP criteria

Isik E. G., Kuyumcu S., Kebudi R., Sanli Y., Karakas Z., CAKIR F. B., et al.

ANNALS OF NUCLEAR MEDICINE , vol.31, no.9, pp.660-668, 2017 (SCI-Expanded, Scopus)

61. Relationships between serum PSA levels, Gleason scores and results of 68Ga-PSMAPET/CT in patients with recurrent prostate cancer.

Sanli Y., Kuyumcu S., Sanli O., Buyukkaya F., Iribas A., Alcin G., et al.

Annals of nuclear medicine , vol.31, no.9, pp.709-717, 2017 (SCI-Expanded, Scopus) Sustainable Development

62. Clinical Utility of Tc-99m MIBI SPECT/CT for Preoperative Localization of Parathyroid Lesions

Ozkan Z. G., Unal S. N., Kuyumcu S., Sanli Y., Gecer M. F., Ozcinar B., et al.

INDIAN JOURNAL OF SURGERY , vol.79, no.4, pp.312-318, 2017 (SCI-Expanded, Scopus)

63. Correlation of F-18-FDG PET/CT with pathological features and survival in primary breast cancer

Has Simsek D., Sanli Y., Kuelle C. B., Karanlik H., Kilic B., Kuyumcu S., et al.

NUCLEAR MEDICINE COMMUNICATIONS , vol.38, pp.694-700, 2017 (SCI-Expanded, Scopus) Sustainable Development

64. Do F-18-FDG PET/CT findings have a relationship with histopathological and immunohistochemical factors of breast cancer in men?

Vatankulu B., Isik G., Kocael P., Kuyumcu S., Ilvan S., Sager S., et al.

NUCLEAR MEDICINE COMMUNICATIONS , vol.37, no.12, pp.1273-1281, 2016 (SCI-Expanded, Scopus) Sustainable Development

65. 68Ga-DOTATATE Pozitron Emisyon Tomografi/Bilgisayarlı Tomografi Görüntülemede Nöroendokrin Tümör Metastazını Taklit Eden İnsidental Soliter Kemik Plazmasitomu

Has Şimşek D., Kuyumcu S., Bilgiç B., Işık E. G., Türkmen C., Adalet I.

Molecular Imaging and Radionuclide Therapy , vol.25, no.3, pp.147-149, 2016 (Peer-Reviewed Journal)

66. An Incidental Solitary Plasmacytoma of Bone Mimicking Neuroendocrine Tumor Metastasis on Ga-68-DOTATATE Positron Emission Tomography/Computed Tomography

Simsek D., Kuyumcu S., Bilgic B., Isik E. G., Turkmen C., Adalet I.

MOLECULAR IMAGING AND RADIONUCLIDE THERAPY , vol.25, no.3, pp.147-149, 2016 (ESCI, TRDizin)

67. Does Metastatic Lymph Node SUVmax Predict Survival in Patients with Esophageal Cancer?

Vatankulu B., Sanli Y., Saglam E. K., Kuyumcu S., Ozkan Z. G., Yilmaz E., et al.

MOLECULAR IMAGING AND RADIONUCLIDE THERAPY , vol.24, no.3, pp.120-127, 2015 (ESCI, TRDizin) Sustainable Development

68. Favorable Survival Time Provided with Radioembolization in Hepatocellular Carcinoma Patients with and Without Portal Vein Thrombosis

Ozkan Z. G., Poyanli A., Ucar A., Kuyumcu S., Akyuz F., Keskin S., et al.

CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS , vol.30, no.3, pp.132-138, 2015 (SCI-Expanded, Scopus)

69. Comparison of Ga-68-DOTATATE PET-CT, F-18-FDG PET-CT and Tc-99m-(V)DMSA scintigraphy in the detection of recurrent or metastatic medullary thyroid carcinoma

Ozkan Z. G., Kuyumcu S., Uzum A. K., Gecer M. F., Ozel S., Aral F., et al.

NUCLEAR MEDICINE COMMUNICATIONS , vol.36, no.3, pp.242-250, 2015 (SCI-Expanded, Scopus)

70. Candida esophagitis mimicking esophageal malignancy on 18FDG PET/CT

Kuyumcu S., Sanli Y., Yegen G., Mudun A.

TURKISH JOURNAL OF GASTROENTEROLOGY , vol.26, no.1, pp.63-64, 2015 (SCI-Expanded, Scopus, TRDizin)

71. Can Complementary Ga-68-DOTATATE and F-18-FDG PET/CT Establish the Missing Link Between Histopathology and Therapeutic Approach in Gastroenteropancreatic Neuroendocrine Tumors?

Simsek D., Kuyumcu S., Turkmen C., Sanli Y., Aykan F., Unal S., et al.

JOURNAL OF NUCLEAR MEDICINE , vol.55, no.11, pp.1811-1817, 2014 (SCI-Expanded, Scopus)

72. Impact of Nonosseous Findings on F-18-NaF PET/CT in a Patient with Ductal Breast Carcinoma

Kuyumcu S., Adalet I., Isik E. G., Unal S.

NUCLEAR MEDICINE AND MOLECULAR IMAGING , vol.48, no.1, pp.72-74, 2014 (ESCI, Scopus)

73. Survival analysis of Y-90 radiosynovectomy in the treatment of haemophilic synovitis of the knee: a 10-year retrospective review

Turkmen C., Kilicoglu Ö. İ., Dikici F., Bezgal F., Kuyumcu S., Gorgun O., et al.

HAEMOPHILIA , vol.20, no.1, 2014 (SCI-Expanded, Scopus)

74. The Value of Somatostatin Receptor Imaging with In-111 Octreotide and/or Ga-68 DOTATATE in Localizing Ectopic ACTH Producing Tumors

ÖZKAN Z. G., KUYUMCU S., Balkose D., ÖZKAN B., AKSAKAL N., Yilmaz E., et al.

MOLECULAR IMAGING AND RADIONUCLIDE THERAPY , vol.22, no.2, pp.49-55, 2013 (ESCI, TRDizin)

75. Microscopic polyangiitis on ¹⁸F-FDG PET/CT of a patient with fever of unknown origin presenting as isolated diffuse renal hypermetabolism.

Kuyumcu S., Turkmen C., Ozluk Y., Kilicaslan I., Unal S. N.

European journal of nuclear medicine and molecular imaging , vol.40, pp.1295-6, 2013 (SCI-Expanded, Scopus)

76. Physiological and tumoral uptake of Ga-68-DOTATATE: standardized uptake values and challenges in interpretation

Kuyumcu S., Ozkan Z. G., Sanli Y., Yilmaz E., Mudun A., Adalet I., et al.

ANNALS OF NUCLEAR MEDICINE , vol.27, no.6, pp.538-545, 2013 (SCI-Expanded, Scopus)

77. Somatostatin receptor scintigraphy with In-111-octreotide in pulmonary carcinoid tumours correlated with pathological and (18)FDG PET/CT findings

Kuyumcu S., Adalet I., Sanli Y., Turkmen C., Ozkan Z. G., Yilmazbayhan D.

ANNALS OF NUCLEAR MEDICINE , vol.26, no.9, pp.689-697, 2012 (SCI-Expanded, Scopus)

78. The utility of FDG-PET/CT as an effective tool for detecting recurrent colorectal cancer regardless of serum CEA levels

Sanli Y., Kuyumcu S., Ozkan Z. G., Kilic L., Balik E., Turkmen C., et al.

ANNALS OF NUCLEAR MEDICINE , vol.26, no.7, pp.551-558, 2012 (SCI-Expanded, Scopus) Sustainable Development

79. Hepatic Adenomatosis May Mimic Metastatic Lesions of Liver With F-18-FDG PET/CT

Sanli Y., Bakir B., Kuyumcu S., Ozkan Z. G., Gulluoglu M., Bilge O., et al.

CLINICAL NUCLEAR MEDICINE , vol.37, no.7, pp.697-698, 2012 (SCI-Expanded, Scopus)

80. The effect of additional delayed images for detection of peritoneal implants with (18)F-fluorodeoxyglucose (FDG) PET/CT

Sanli Y., Kuyumcu S., Yilmaz E., Ozkan Z., Gungor F., Turkmen C., et al.

JOURNAL OF NUCLEAR MEDICINE , vol.53, 2012 (SCI-Expanded)

81. Role of red blood cell scintigraphy for determining the localization of gastrointestinal bleeding

Sanli Y., Ozkan Z. G., Kuyumcu S., Yanar H., Balik E., Tokmak H., et al.

ULUSAL TRAVMA VE ACIL CERRAHI DERGISI-TURKISH JOURNAL OF TRAUMA & EMERGENCY SURGERY , vol.18, no.3, pp.225-230, 2012 (SCI-Expanded, Scopus, TRDizin)

82. Increased FDG uptake in breast cancer is associated with prognostic factors

Sanli Y., Kuyumcu S., Ozkan Z. G., Isik G., Karanlik H., Guzelbey B., et al.

ANNALS OF NUCLEAR MEDICINE , vol.26, no.4, pp.345-350, 2012 (SCI-Expanded, Scopus) Sustainable Development

83. İyi diferansiye tiroid kanseri hastalarında rekürrens veya metastaz şüphesinde F18 FDG PET BT nin yeri

ÖZKAN Z. G., ŞANLI Y., KUYUMCU S., YILMAZ E., ADALET I., ÜNAL S. N.

Endokrinolojide Diyalog Dergisi , vol.9, no.2, pp.57-63, 2012 (Peer-Reviewed Journal)

84. Is there a relationship between CEA levels and FDG-PET/CT findings in patients with recurrent colorectal cancer?

Sanli Y., Kadioglu N., Turkmen C., Asoglu O., Unal S., Adalet I., et al.

JOURNAL OF NUCLEAR MEDICINE , vol.52, 2011 (SCI-Expanded) Sustainable Development

85. Diagnostic spectrum of congenital hypothyroidism in Turkish children

Tamam M., Adalet I., Bakir B., Tuerkmen C., Darendeliler F., Bas F., et al.

PEDIATRICS INTERNATIONAL , vol.51, no.4, pp.464-468, 2009 (SCI-Expanded, Scopus)

Papers Presented at Peer-Reviewed Scientific Conferences 56

1. Incidental Detection of Non-Ossifying Fibroma in Pediatric Oncology: FDG PET/CT Features and Diagnostic Pitfalls

Arça B., Işık E. G., Bayramoğlu Z., Aslaner K., Özkan Z. G., Kuyumcu S.

Annual Congress of the European Association of Nuclear Medicine (EANM'25), Barcelona, Spain, 4 - 08 October 2025, pp.118, (Summary Text)

2. TEMPOROMANDİBULAR EKLEM ASİMETRİSİNDE 99mTc-MDP SİNTİGRAFİSİNİN TANISAL PERFORMANSI

Akar S. R., Işık E. G., Kozanoğlu E., Arça B., Kuyumcu S.

37. Ulusal Nükleer Tıp Kongresi, Antalya, Turkey, 9 - 13 April 2025, pp.1-17, (Full Text)

3. Beyaz Adipoz Dokuda Artmış FDG Tutulumu, HIV ile İlişkili Lipodistrofiyi Öngörebilir Mi?

Arça B., Arslan D. F., Kuyumcu S., Şanlı Y.

37. Ulusal Nükleer Tıp Kongresi, Antalya, Turkey, 9 - 13 April 2025, pp.234, (Summary Text)

4. Pediatrik Onkoloji Hastalarında İnsidental Saptanan Nonossifiye Fibrom: F-18 FDG PET/BT Bulguları ve Tanısal Zorluklar

Arça B., Işık E. G., Bayramoğlu Z., Aslaner K., Özkan Z. G., Kuyumcu S.

37. Ulusal Nükleer Tıp Kongresi, Antalya, Turkey, 9 - 13 April 2025, pp.193, (Summary Text)

5. Kardiyak Amiloidoz Tanısında Kantitatif ve Semikantitatif Değerlendirme: Hangisi Daha Güvenilir?

İnal E., Zorkun C. S., Arça B., Işık E. G., Kuyumcu S., Şanlı Y.

37. Ulusal Nükleer Tıp Kongresi, Antalya, Turkey, 9 - 13 April 2025, pp.190, (Summary Text)

6. A New Promising Tool for Primary Hyperparathyroidism: 68Ga-Trivehexin PET/CT

Denizmen Zorba D., Kuyumcu S., Has Şimşek D., Poyanlı A., Büyükkaya F., Özkan Z. G., et al.

EANM, Hamburg, Germany, 19 - 23 October 2024, pp.172-173, (Summary Text)

7. The Role of 68Ga-Pentixafor PET/CT in The Diagnosis of Chronic Bone and Soft Tissue Infections

Denizmen Zorba D., Kuyumcu S., Has Şimşek D., Karaçam M. İ., Ergin Ö. N., Çağatay A. A., et al.

EANM, Hamburg, Germany, 19 - 23 October 2024, pp.332, (Summary Text)

8. The utility of quantitative parameters of dynamic myocardial perfusion imaging performed by cardiac dedicated CZT gamma camera

Civan C., Has Şimşek D., Arslan D. F., Denizmen Zorba D., Emet S., Işık E. G., et al.

EANM, Hamburg, Germany, 19 - 23 October 2024, pp.5615, (Summary Text)

9. Tc-99m Labeled Erythrocyte Scintigraphy Reveals Giant Mediastinal Cavernous Hemangioma Mimicking Malignancy on FDG PET/CT

Arça B., Has Şimşek D., Şanlı Y., Kuyumcu S.

Annual Congress of the European Association of Nuclear Medicine (EANM'24), Hamburg, Germany, 19 - 23 October 2024, vol.51, pp.864-865, (Summary Text) Sustainable Development

10. Contribution of 18F-FDG MAMMI-PET Imaging in Breast Cancer Staging

ASLANER K., HAS ŞİMŞEK D., ARSLAN D. F., YILMAZ R., ÖNDER S., CABIOĞLU N., et al.

Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Hamburg, Germany, 19 - 23 October 2024, (Summary Text)

11. A New Promising Tool for Primary Hyperparathyroidism: ⁶⁸Ga-Trivehexin PET/CT

Denizmen D., KUYUMCU S., HAS ŞİMŞEK D., POYANLI A., BÜYÜKKAYA F., ÖZKAN Z. G., et al.

Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Hamburg, Germany, 19 - 23 October 2024, vol.51, (Summary Text) Sustainable Development

12. Y-90 Mikroküre Tedavisinde Bireysel Akciğer RadyasyonDozunun Hesaplanması

Asa S., Kovan B., Çavdar İ., Kuyumcu S.

36. ULUSAL NÜKLEER TIP KONGRESİ, Girne, Cyprus (Kktc), 8 - 12 May 2024, pp.105, (Summary Text)

13. GENİŞLETİLMİŞ 177LU-PSMA TEDAVİSİ UYGULANAN HASTALARDA ABSORBE BÖBREK DOZU CKD-EPİ DEĞERLERİNİ NASIL ETKİLİYOR?

, Topal E., Kovan B., İribaş Çelik A., Kuyumcu S., Başaran M., et al.

36. Ulusal Nükleer Tıp Kongresi, Girne, Cyprus (Kktc), 8 - 12 May 2024, pp.11, (Summary Text)

14. F-18 FDG PET/BT’de Maligniteyi Taklit Eden Mediastinal Hemanjiyomun Tc-99m İşaretli Eritrosit Sintigrafisi ile Tespiti

Arça B., Has Şimşek D., Şanlı Y., Kuyumcu S.

36. ULUSAL NÜKLEER TIP KONGRESİ, Girne, Cyprus (Kktc), 8 - 12 May 2024, pp.209, (Summary Text) Sustainable Development

15. Contribution of SPECT-CT in the Differentiation of Ectopic Thyroid Tissue and Thyroglossal Duct Cyst

Deniz G., Işık E. G., Has Şimşek D., Şanlı Y., Arça B., Kuyumcu S.

EANM'23, Vienna, Austria, 9 - 13 September 2023, pp.793, (Full Text)

16. The efficacy of prognostic factors derived from Ga68-PSMA PET-CT images in predicting treatment response and survival in patients with metastatic castration-resistant prostate cancer treated with Lu-177PSMA

Oflas M., Has Şimşek D., Şanlı Y., Kuyumcu S., Işık E. G., Karadoğan S., et al.

EANM’23, Vienna, Austria, 9 - 13 September 2023, (Full Text) Sustainable Development

17. Role of 68Ga-DOTATATE PET/CT Quantitative Parameters in the Differential Diagnosis of Adrenal Lesions

DENİZMEN ZORBA D., HAS ŞİMŞEK D., IŞIK E. G., HACİŞAHİNOĞULLARI H., KUYUMCU S.

Annual Congress of the European Association of Nuclear Medicine, Viyana, Austria, 9 - 13 September 2023, vol.50, pp.299, (Summary Text)

18. PSMA Hedefli Radyonüklid Tedavilerde Botulinum Toksini ile Tükrük Bezi Radyoproteksiyonu

Denizmen D., Has Şimşek D., Akalın B. E., Kuyumcu S., Şanlı Y.

35. UNTK, Antalya, Turkey, 26 - 30 April 2023, pp.131, (Full Text)

19. Pediatrik Nöroektodermal Tümörlerde 68Ga-DOTATATE PET BT

Denizmen D., Işık E. G., Civan C., Has Şimşek D., Kuyumcu S.

35. UNTK, Antalya, Turkey, 26 - 30 April 2023, pp.57, (Summary Text)

20. Adrenal Lezyonlarının Ayırıcı Tanısında Ga-68 DOTATATE PET/BT Kantitatif Parametrelerinin Rolü

Denizmen D., Has Şimşek D., Işık E. G., Hacışahinoğulları H., Kuyumcu S.

35. UNTK, Antalya, Turkey, 26 - 30 April 2023, pp.77-78, (Summary Text)

21. CZT Kardiyak Kamera ile Hesaplanan Koroner Kan Akımı Verilerinin Miyokard Perfüzyon Sintigrafisine Katkısı

Arslan D. F., Has Şimşek D., Denizmen D., Özkan Z. G., Emet S., Kuyumcu S.

35. ULUSAL NÜKLEER TIP KONGRESİ, Antalya, Turkey, 26 - 30 April 2023, vol.9, no.43, pp.45-47, (Summary Text)

22. LU177-PSMA TEDAVİSİ VERİLEN PROSTAT KANSERLİ HASTALARDA GA-68 PET/BT İLE TEDAVİ YANITI VE PROGNOSTİK DEĞERLENDİRME

Oflas M., Has Şimşek D., Şanlı Y., Kuyumcu S., Işık E. G., Karadoğan S., et al.

35. Ulusal Nükleer Tıp Kongresi, Antalya, Turkey, 26 - 30 April 2023, (Summary Text) Sustainable Development

23. Addüktör İnsersiyo Avülsiyon Sendromunda Tüm Vücut Kemik Sintigrafisi

Arça B., Arslan D. F., Has Şimşek D., Mudun A., Kuyumcu S.

35. ULUSAL NÜKLEER TIP KONGRESİ, Antalya, Turkey, 26 - 30 April 2023, vol.9, pp.153, (Summary Text)

24. Incidental Cardiac 68Ga-FAPI-04 Uptake Related to Cardiovascular Diseases: Case Reports

Denizmen D., Has Şimşek D., Işık E. G., Mudun A., Kuyumcu S.

EANM 2022 Congress, Barcelona, Spain, 15 - 19 October 2022, pp.671, (Full Text)

25. [68Ga]Ga-FAPI-04 and [18F]FDG PET/CT in Patients With Primary Liver Malignancies

Karadoğan S., Şanlı Y., Ertürk Ş. M., İbiş A. C., Kuyumcu S.

35th Annual Congress of the European Association of Nuclear Medicine, Barcelona, Spain, 15 - 19 October 2022, pp.41, (Summary Text)

26. Primer Karaciğer Malignitelerinde F-18 FDG ve Ga-68 FAPİ PET/BT Karşılaştırılması ve Tümör Belirteçleriyle Korelasyonu

Karadoğan S., Şanlı Y., İbiş A. C., Ertürk Ş. M., Kuyumcu S.

34. Ulusal Nükleer Tıp Kongresi, Antalya, Turkey, 27 - 31 March 2022, pp.56-57, (Summary Text)

27. İnsidental Kardiyak Ga-18 FAPİ-04 Tutulumunun Kardiyovasküler Hastalıklar ile İlişkisi: Üç Olgu Sunumu

Denizmen D., Has Şimşek D., Işık E. G., Mudun A., Kuyumcu S.

34. UNTK, Antalya, Turkey, 27 - 31 March 2022, pp.104-105, (Full Text)

28. Timik Epitelyal Tümörlerde Ga-68 DOTATATE PET/BT Görüntüleme Caner

Civan C., Özkan Z. G., Özkan B., Işık E. G., Has Şimşek D., Aydıner A., et al.

34. ULUSAL NÜKLEER TIP KONGRESI , Antalya, Turkey, 27 March - 31 May 2022, pp.16, (Summary Text)

29. MPS’de Koroner Kan Akımı Rezervinin İskemik Hastalığın Tespitindeki Rolü ve Klinik Risk Grubu ile İlişkisi: İlk Sonuçlar

Denizmen D., Has Şimşek D., Işık E. G., Özkan Z. G., Şanlı Y., Kuyumcu S.

34. UNTK, Antalya, Turkey, 27 - 31 March 2022, pp.45, (Full Text)

30. Metastatik kastrasyona dirençli prostat kanserinde Ac-225 PSMA tedavisi: İlk sonuçlarımız

Şanlı Y., Has Şimşek D., Işık E. G., Civan C., Başaran M., Özkan Z. G., et al.

33. Ulusal Nükleer Tıp Kongresi, 28 May 2021, pp.32, (Summary Text) Sustainable Development

31. Prostat Kanseri Tanılı Olgularda İnsidental Olarak Saptanan Akciğer Lezyonlarında Ga-68 PSMA PET/BT’nin Rolü

Kıran M. Y., Has Şimşek D., Işık E. G., Kuyumcu S., Özkan Z. G., Şanlı Y.

33. Ulusal Nükleer Tıp Kongresi, İstanbul, Turkey, 28 - 29 May 2021, pp.12-13, (Summary Text) Sustainable Development

32. Tc-99m DMSA sintigrafisinde separe böbrek fonksiyonu hesaplamada planar (2D) ve SPECT (3D) yöntemlerinin karşılaştırılması

Civan C., Has Şimşek D., Kıran M. Y., Işık E. G., Özkan Z. G., Kuyumcu S., et al.

33. Ulusal Nükleer Tıp Kongresi, 28 May 2021, pp.46, (Summary Text)

33. COVID-19 SONRASI ANTİKOAGÜLAN KULLANAN HASTADA BİLATERAL EMBOLİNİN AKCİĞER PERFÜZYON SİNTİGRAFİSİ İLE GÖSTERİLMESİ

Denizmen D., Işık E. G., Erelel M., Kuyumcu S., Ünal S. N.

33. Ulusal Nükleer Tıp Kongresi, İstanbul, Turkey, 28 - 29 May 2021, pp.1-2, (Full Text)

34. Lu-177 DOTATATE Tedavisi Alan Tiroid Kanseri Hastalarında Ga-68 DOTATATE PET/BT ve Tümör Belirteçlerinin Rolü

Civan C., Işık E. G., Has Şimşek D., Kuyumcu S., Karadoğan S., Paksoy N., et al.

33. Ulusal Nükleer Tıp Kongresi, İstanbul, Turkey, 28 - 29 May 2021, pp.33-34, (Full Text) Sustainable Development

35. Tc-99m-MAG3 Sintigrafisinde Tanımlanan EkskresyonFonksiyonunun Lu-177-PSMA Tedavisindeki AbsorbeBöbrek Dozuyla İlişkisi

CİVAN C., HAS ŞİMŞEK D., KOVAN B., BÜYÜKKAYA F., KUYUMCU S., MUDUN A., et al.

32. ULUSAL NÜKLEER TIP KONGRESİ, İstanbul, Turkey, 20 - 21 November 2020, vol.6, pp.26-27, (Full Text)

36. Lobektomi planlanan hastada kantitatif akciğer perfüzyon sintigrafisine SPECT BT’nin katkısı: Olgu sunumu

CİVAN C., KOVAN B., IŞIK E. G., ÖZKAN Z. G., OKUMUŞ N. G., KUYUMCU S., et al.

32. Ulusal Nükleer Tıp Kongresi, Turkey, 20 - 21 November 2020, (Summary Text)

37. Role of [68Ga]-pentixafor-PET/CT as a novel imaging of cxcr4 expression in multiple myeloma comparison to [18F]-FDG-PET/CT

TİRYAKİ T. O., KUYUMCU S., HAS ŞİMŞEK D., ÖZBALAK M. M., KUBİLAY D. Ö., ÜNAL S. N., et al.

Xth International Eurasian Hematology-Oncology Congress, İstanbul, Turkey, 8 - 12 October 2019, vol.85, (Summary Text)

38. Ga-68-Pentixafor PET: Hematolojik Malignitelerde Kemokin-4 Reseptör Hedefli Yaklaşım ve F-18-FDG PET ileKarşılaştırılması

ENGİN M. N., HAS ŞİMŞEK D., ŞANLI Y., BEŞIŞIK S., KUYUMCU S.

31. ULUSAL NÜKLEER TIP KONGRESi, Turkey, 10 - 14 April 2019, vol.1, pp.3, (Summary Text)

39. Comparison of Ga-68-PSMA PET/CT and Bone Scintigraphy for the Diagnosis of Bone Metastasis of Prostate Cancer

ENGİN M. N., HAS ŞİMŞEK D., CİVAN C., KUYUMCU S., ŞANLI Y.

8th BALKAN CONGRESS OF NUCLEAR MEDICINE, Bodrum, Turkey, 10 - 14 April 2019, vol.1, pp.7, (Summary Text)

40. Hepatosellüler Karsinomda Ga-PSMA PET/BT’nin Rolü

HAS ŞİMŞEK D., KUYUMCU S., İLİAZ R., ŞANLI Y., BÜYÜKKAYA F., AKYÜZ F., et al.

31. ULUSAL NÜKLEER TIP KONGRESİ, Antalya, Turkey, 10 - 14 April 2019, vol.1, pp.21, (Summary Text)

41. Ga-68 DOTA-peptid PET/BT’de saptanan Ga-68 DOTATATE (+) meme lezyonlarının değerlendirilmesi

Karabacak M. N., Has Şimşek D., Özkan Z. G., Kuyumcu S., Ünal S. N., Mudun A.

30. Ulusal Nükleer Tıp Kongresi, Antalya, Turkey, 11 April 2018, pp.40, (Summary Text)

42. Bilateral femur başı geç dönem avasküler nekrozunun sebep olduğu ciddi enflamasyonu göstermede alternatif bir yöntem: FDG PET/BT

Özkan Z. G., Kuyumcu S., Akpınar T. S., Ertek F., Ünal S. N.

30. Ulusal Nükleer Tıp Kongresi, Antalya, Turkey, 11 April 2018, pp.97, (Summary Text)

43. Accuracy of 18F-FDG-PET/CT in staging, restaging, and treatment response in patients with male breast cancer

Vatankulu B., Kuyumcu S., Kocael P. C., Işık E., Asa S., Sager S., et al.

28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Hamburg, Germany, 10 - 14 October 2015, vol.42, (Summary Text) Sustainable Development